KLK3 and metastatic prostate carcinoma: Hormone-naive, or ‘castrate sensitive’ advanced prostate cancer (CSPC) is characterized by non-castrate testosterone levels and includes clinical disease states ranging from patients with prostate specific antigen (PSA) recurrence to those patients with metastatic prostate cancer detected by imaging.